EBG00000313325 - n.514A>C
Drug resistance types
0 Sensitive
10 RR-TB
139 HR-TB
461 MDR-TB
601 Pre-XDR-TB
23 XDR-TB
108 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.2 | 464 |
| lineage4.9;lineage3 | 1 |
| lineage2.2.1 | 344 |
| lineage4.3.3 | 219 |
| lineage3 | 48 |
| lineage1.2.2.2 | 12 |
| lineage3.1.3 | 14 |
| lineage4.1.2 | 1 |
| lineage4.6.1.2 | 6 |
| lineage1.2.1.2.1 | 12 |
| 8 | |
| lineage4.9 | 8 |
| lineage2.2.1.1 | 33 |
| lineage4.8 | 24 |
| lineage1.1 | 1 |
| lineage4.1.2.1 | 13 |
| lineage4.3.3;lineage2.2.1 | 7 |
| lineage4.8;lineage2.2.1 | 2 |
| lineage4.2.2.2 | 15 |
| lineage2.2 | 7 |
| lineage4.2.1.1 | 1 |
| lineage4.3.3;lineage4.2.1 | 1 |
| lineage4.2.2.1 | 1 |
| lineage4.2.1 | 1 |
| lineage3.1.2 | 9 |
| lineage4.3.2.1;lineage2.2.2 | 2 |
| lineage1.1.1.1 | 8 |
| lineage4.7 | 1 |
| lineage4.3.2.1 | 8 |
| lineage4.1.1.3;lineage2.2.2 | 1 |
| lineage4.6;lineage3 | 1 |
| lineage1.1.2 | 9 |
| lineage4.5 | 4 |
| lineage3.1.1 | 7 |
| lineage2.2.1;lineage1.1.1.1 | 3 |
| lineage4.9;lineage2.2.2 | 1 |
| lineage4.6.1.1 | 1 |
| lineage4.1 | 1 |
| lineage4.1.1.3;lineage2.2.1 | 1 |
| lineage4.4.2 | 3 |
| lineage4.6.2.2 | 2 |
| lineage1.1.3.2 | 2 |
| lineage4.3.4.1 | 4 |
| lineage4.3.4.2 | 2 |
| lineage4.4.1.2;lineage2.2.1 | 1 |
| lineage4.6;lineage2.2.1 | 1 |
| lineage4.3.1 | 5 |
| lineage5.1.1 | 1 |
| lineage4.1.3 | 2 |
| lineage3.1.3;lineage3.1.1 | 1 |
| lineage1.2.1.2 | 3 |
| lineage4.6 | 2 |
| lineage1.1.3 | 1 |
| lineage3.1.2;lineage2.2.1 | 1 |
| lineage4.1.1 | 1 |
| lineage3.1.2.1 | 1 |
| lineage6.2.1 | 1 |
| lineage4.4.1.1.1 | 2 |
| lineage2.2.2;lineage2.2.1.1 | 1 |
| lineage4.6.5 | 1 |
| lineage4.8.2;lineage3.1.3 | 1 |
| lineage4.2.2 | 1 |
| lineage2.2.2;lineage2.2.1 | 1 |
| lineage2.1 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 1342 |
Geographic prevalence
Country level data for this variant is available for 1000 isolates.
Statisctical support
Not enough data to calculate support.
Samples
This table has 1342 rows and could cause your browser to crash if rendered.
